Fidelis Capital Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73M | Buy |
16,768
+239
| +1% | +$24.6K | 0.16% | 113 |
|
|
2025
Q1 | $1.68M | Sell |
16,529
-1
| -0% | -$102 | 0.18% | 102 |
|
|
2024
Q4 | $1.7M | Buy |
16,530
+2,621
| +19% | +$270K | 0.17% | 106 |
|
|
2024
Q3 | $1.22M | Sell |
13,909
-1,199
| -8% | -$105K | 0.14% | 126 |
|
|
2024
Q2 | $1.11M | Buy |
15,108
+1,263
| +9% | +$93.2K | 0.16% | 115 |
|
|
2024
Q1 | $948K | Buy |
13,845
+809
| +6% | +$55.4K | 0.14% | 136 |
|
|
2023
Q4 | $754K | Buy |
13,036
+4,138
| +47% | +$239K | 0.17% | 124 |
|
|
2023
Q3 | $470K | Buy |
8,898
+788
| +10% | +$41.6K | 0.16% | 137 |
|
|
2023
Q2 | $439K | Sell |
8,110
-292
| -3% | -$15.8K | 0.16% | 143 |
|
|
2023
Q1 | $433K | Buy |
+8,402
| New | +$433K | 0.18% | 132 |
|